William Burke - Adtalem Global Lead Independent Director
| ATGE Stock | USD 72.09 0.68 0.93% |
Director
Mr. William W. Burke is Lead Independent Director of the Company. Since November 2015, Mr. Burke has served as President of Austin Highlands Advisors, LLC, a provider of corporate advisory services. He served as Executive Vice President Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company was acquired by Abbott Laboratories in August 2013. From August 2004 to December 2007, he served as Executive Vice President Chief Financial Officer of ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006 and subsequently merged with DJO Incorporated in November 2007. Mr. Burke remained with ReAble until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporationrationration, a medical diagnostic products company. Mr. Burke has served on the Board of numerous public and private company boards and currently serves on the Board of Invuity, Inc., Tactile Systems Technology, Inc., and Myocardial Solutions, Inc. He previously served on the Board of LDR Holding Corporation and Medical Action Industries since 2019.
| Age | 61 |
| Tenure | 5 years |
| Professional Marks | MBA |
| Address | 500 West Monroe Street, Chicago, IL, United States, 60661 |
| Phone | 312 651 1400 |
| Web | https://www.adtalem.com |
William Burke Latest Insider Activity
Tracking and analyzing the buying and selling activities of William Burke against Adtalem Global stock is an integral part of due diligence when investing in Adtalem Global. William Burke insider activity provides valuable insight into whether Adtalem Global is net buyers or sellers over its current business cycle. Note, Adtalem Global insiders must abide by specific rules, including filing SEC forms every time they buy or sell Adtalem Global'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
William Burke over six months ago Disposition of 1053 shares by William Burke of Carnival Plc at 11.6695 subject to Rule 16b-3 |
Adtalem Global Management Efficiency
The company has return on total asset (ROA) of 0.0612 % which means that it generated a profit of $0.0612 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0974 %, meaning that it created $0.0974 on every $100 dollars invested by stockholders. Adtalem Global's management efficiency ratios could be used to measure how well Adtalem Global manages its routine affairs as well as how well it operates its assets and liabilities. At present, Adtalem Global's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Adtalem Global's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 89.1 M, whereas Net Tangible Assets are projected to grow to (270.4 M).Similar Executives
| Found 2 records | DIRECTOR Age | ||
| Frank Tutalo | American Public Education | N/A | |
| Huiyan Yang | Bright Scholar Education | 38 | |
Management Performance
| Return On Equity | 0.0974 | ||||
| Return On Asset | 0.0612 |
Adtalem Global Education Leadership Team
Elected by the shareholders, the Adtalem Global's board of directors comprises two types of representatives: Adtalem Global inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adtalem. The board's role is to monitor Adtalem Global's management team and ensure that shareholders' interests are well served. Adtalem Global's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adtalem Global's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Danaher, President Adtalem Medical and Veterinary | ||
| MVB MRCVS, Dean | ||
| Lisa Wardell, Chairman of the Board, President, Chief Executive Officer | ||
| William Burke, Lead Independent Director | ||
| Stephen Beard, President, Chief Executive Officer, Director | ||
| Chaka Patterson, Senior Vice President General Counsel, Corporate Secretary | ||
| Douglas Beck, Senior Vice President, General Counsel, Corporate Secretary | ||
| Jeff Tognola, Chief Operating Officer | ||
| Kathy Holland, Group President - Medical and Healthcare Education | ||
| William Owen, Dean Medicine | ||
| Fernando Lau, Senior Vice President Chief Marketing Officer | ||
| Josh Braunstein, President Managing Director - Becker Professional Education and Presidentident of OnCourse Learning | ||
| Cheryl James, Senior Vice President Chief Human Resource Officer | ||
| MBA MD, Executive Dean | ||
| John MD, Pres Veterinary | ||
| Robert Phelan, Interim Chief Financial Officer, Chief Accounting Officer, Vice President | ||
| Nancy Johnson, Interim Chief Human Resources Officer | ||
| Steven Tom, Senior Vice President Chief Customer Officer | ||
| Roger Mckinney, Interim President of Walden University | ||
| James Bartholomew, Senior Vice President, Chamberlain University and Institutional Shared Services | ||
| Christopher Nash, Senior Vice President, Chief Information Officer | ||
| Georgette Kiser, Independent Director | ||
| Michael Malafronte, Independent Director | ||
| Sharon OKeefe, Independent Director | ||
| James White, Independent Director | ||
| Charles DeShazer, Independent Director | ||
| Kenneth Phelan, Independent Director | ||
| Manjunath Gangadharan, VP Officer | ||
| Donna Jennings, Senior Vice President, Chief Human Resources Officer | ||
| Maurice Herrera, Senior Vice President, Chief Marketing Officer | ||
| Michael Randolfi, Chief Financial Officer, Principal Financial Officer | ||
| Michael Betz, President University | ||
| Karen Cox, President of Chamberlain University | ||
| Lyle Logan, Independent Director | ||
| Mayur Gupta, Independent Director | ||
| Blake Simpson, Senior Officer | ||
| CertVR DipECVP, Dean | ||
| Sara Hill, Chief Officer | ||
| Chandrika Nigam, Director Relations | ||
| Donna Hrinak, Independent Director | ||
| Larry Bachman, Interim General Counsel |
Adtalem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adtalem Global a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0974 | ||||
| Return On Asset | 0.0612 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 3.35 B | ||||
| Shares Outstanding | 37.69 M | ||||
| Shares Owned By Insiders | 2.11 % | ||||
| Shares Owned By Institutions | 97.89 % | ||||
| Number Of Shares Shorted | 935.75 K | ||||
| Price To Earning | 38.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adtalem Global Education. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Diversified Consumer Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adtalem Global. If investors know Adtalem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adtalem Global listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.575 | Earnings Share 3.42 | Revenue Per Share 40.206 | Quarterly Revenue Growth 0.124 | Return On Assets 0.0612 |
The market value of Adtalem Global Education is measured differently than its book value, which is the value of Adtalem that is recorded on the company's balance sheet. Investors also form their own opinion of Adtalem Global's value that differs from its market value or its book value, called intrinsic value, which is Adtalem Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adtalem Global's market value can be influenced by many factors that don't directly affect Adtalem Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adtalem Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adtalem Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adtalem Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.